BSECompany Update2d ago · 5 Nov 2026, 01:25 pm

Please find attached intimation regarding ESG Rating

Mankind Pharma Ltd · 543904

✦ AI SummaryESG

Mankind Pharma Ltd has been assigned an ESG rating of 64.8 by SES ESG Research Private Limited, a SEBI registered ESG rating provider, for FY26 based on publicly available information.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Mankind Pharma Ltd - 543904 - Intimation Regarding ESG Rating

Attachments (1)

📄

9650eb76-ab33-449d-b193-d822f5a21f6c.pdf

pdf

Download →
View document text
November 5, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Subject: Intimation of Environmental, Social and Governance (ESG) Rating Ref.: Regulation 30 & 51 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) With reference to the captioned subject, we wish to inform you SES ESG Research Private Limited (“SES”), a SEBI registered ESG Rating Provider, has assigned the Environmental, Social, and Governance (ESG) Rating of ‘64.8’ to the Company. The Company has not engaged SES for the said rating, same has been independently assigned by SES for FY26, based on publicly available information. The above disclosure is also being made available on the Company’s website at www.mankindpharma.com. This is for your information and records. Thanking You, Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer